Genentech, Inc. et al v. Sandoz, Inc.

1:19-cv-00203 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Richard G. Andrews
Filed Jan. 31, 2019
Terminated April 19, 2022
Case Flags CLOSED and PATENT
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Cause 35:271 Patent Infringement
Jury Demand None
Lead Case 1:19-cv-00078
Last Updated: 6 months, 2 weeks ago Show Interactive Timeline
Filing Date # Docket Text
4/20/2022Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,767,225 B2; 7,988,994 B2; 8,383,150 B2; 8,753,679 B2; 7,696,236 B2; 7,767,700 B2; 8,420,674 B2; 7,566,729 B1; 7,635,707 B1; 8,592,462 B2; 8,609,701 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (Attachments: # 1 Final Judgment)(nms) (Entered: 04/20/2022)
4/19/2022CASE CLOSED per entry of D.I. 396 in Lead Civil Action 19-78-RGA. Associated Cases: 1:19-cv-00078-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA(nms) (Entered: 04/19/2022)
4/1/2022CASE NO LONGER REFERRED to Magistrate Judge Fallon for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. Associated Cases: 1:19-cv-00202-RGA, 1:19-cv-00203-RGA(lih) (Entered: 04/01/2022)
9/20/2019CORRECTING ENTRY: The Answer filed at D.I. 26, Disclosure Statement filed at D.I. 27, and the Notices of Service filed at D.I. 28 and 31 have been removed from the docket. Filings are to be made in the Lead Civil Action only. (nms) (Entered: 09/20/2019)
9/17/2019
  • Order
SO ORDERED, re (30 in 19-cv-203-RGA, 21 in 19-cv-136-RGA, 30 in 19-cv-202-RGA, 20 in 19-cv-177-RGA) MOTION for Pro Hac Vice Appearance of Attorney Cindy Chang and Kevin Dejong, filed by Lek Pharmaceuticals d.d., Sandoz AG, Alembic Pharmaceuticals, Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Teva Pharmaceuticals USA, Inc., Alembic Global Holding SA, Sandoz, Inc., Alembic Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 9/17/2019. Associated Cases: 1:19-cv-00136-RGA, 1:19-cv-00177-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA(nms) (Entered: 09/17/2019)
9/17/2019
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Cindy Chang and Kevin Dejong - filed by Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Lek Pharmaceuticals d.d., Sandoz AG, Sandoz International GmbH, Sandoz, Inc.. (Attachments: # 1 Certification of Cindy Chang, # 2 Certification of Kevin DeJong)(Brauerman, Stephen) (Entered: 09/17/2019)
9/16/2019Official Transcript of Scheduling Conference held on 08/20/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/7/2019. Redacted Transcript Deadline set for 10/17/2019. Release of Transcript Restriction set for 12/16/2019. (Triozzi, Heather) (Entered: 09/16/2019)
9/3/2019CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:19-cv-00078-RGA et al.(cak) (Entered: 09/03/2019)
9/3/2019
  • Scheduling Order
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 11/12/2020. Joint Claim Construction Brief due by 8/26/2020. A Markman Hearing is set for 9/23/2020, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 10/22/2021, at 8:30 AM in Courtroom 6A. A Bench Trial is set for 11/8/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) (Entered: 09/03/2019)
8/30/2019PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Letter)(Jacobs, Karen) Modified on 8/30/2019 (nms). (Entered: 08/30/2019)
8/20/2019Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 8/20/2019. Local counsel present for plaintiffs: J. Blumenfeld. Local counsel present for defendants: S. Brauerman, A. Orlacchio, S. O'Byrne, S. Stamoulis, A. Gaza, E. Ormerod, B. Schladweiler, J. Parshall, M. Haney, K. Dorsney. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-cv-00078-RGA et al.(crb) (Entered: 08/20/2019)
8/16/2019 PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Letter)(Jacobs, Karen) Modified on 8/20/2019 (nms). (Entered: 08/16/2019)
6/25/2019
  • Answer
ANSWER to 20 Answer to Amended Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Blumenfeld, Jack) Modified on 6/25/2019 (nms). (Entered: 06/25/2019)
6/11/2019WAIVER OF SERVICE returned executed by Genentech, Inc., InterMune, Inc.: For Lek Pharmaceuticals d.d. waiver sent on 6/6/2019, answer due 8/5/2019. (Blumenfeld, Jack) (Entered: 06/11/2019)
6/4/2019
  • Answer
ANSWER to 18 Amended Complaint, and COUNTERCLAIM against Genentech, Inc., InterMune, Inc., by Sandoz, Inc..(Brauerman, Stephen) Modified on 6/5/2019 (nms). (Entered: 06/04/2019)
5/24/2019
  • Answer
ANSWER to 15 Answer to Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Blumenfeld, Jack) Modified on 5/28/2019 (nms). (Entered: 05/24/2019)
5/22/2019Summons Issued with Magistrate Consent Notice attached as to Lek Pharmaceuticals d.d. on 5/22/2019. (ceg) (Entered: 05/22/2019)
5/22/2019CORRECTING ENTRY: The unsigned summons attached to the filing at D.I. 18 has been removed. Summons are not to be filed but presented to the Clerk's Office for issuance. (nms) (Entered: 05/22/2019)
5/21/2019
  • Complaint
First AMENDED COMPLAINT for Patent Infringement against Sandoz, Inc., Lek Pharmaceuticals d.d. - filed by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-19)(Blumenfeld, Jack) Modified on 5/22/2019 (nms). (Entered: 05/21/2019)
5/16/201917
  • Order
ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Tuesday, August 20, 2019, at 2:30 p.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiffs counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. Parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. The parties shall direct any requests or questions regarding the scheduling or management of this case to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 5/16/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) (Entered: 05/16/2019)
5/16/2019Pro Hac Vice Attorney Elaine H. Blais, Natasha E. Daughtrey, Emily L. Rapalino, and Srikanth K. Reddy for Sandoz, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) (Entered: 05/16/2019)
5/3/2019 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Novartis AG for Sandoz, Inc. filed by Sandoz, Inc.. (Brauerman, Stephen) (Entered: 05/03/2019)
5/3/2019
  • Answer
ANSWER to 1 Complaint, and COUNTERCLAIM against Genentech, Inc., InterMune, Inc., by Sandoz, Inc..(Brauerman, Stephen) Modified on 5/3/2019 (nms). (Entered: 05/03/2019)
5/3/2019
  • Motion to Dismiss (Demurrer)Granted
SO ORDERED Granting 13 Stipulation and Order Dismissing Without Prejudice Defendants Sandoz International GMBH and Sandoz AG and Amending Caption (*Sandoz AG and Sandoz International GmbH terminated). Signed by Judge Richard G. Andrews on 5/2/2019. (nms) (Entered: 05/03/2019)
5/2/2019
  • Motion to Dismiss (Demurrer)by Δ
STIPULATION and [Proposed] Order Dismissing Without Prejudice Defendants Sandoz International GMBH and Sandoz AG and Amending Caption by Sandoz AG, Sandoz International GmbH, Sandoz, Inc.. (Brauerman, Stephen) (Entered: 05/02/2019)
4/23/2019
  • Motion to Extend Time
SO ORDERED, re 12 STIPULATION and Order to Extend Time to Answer, Move, or otherwise respond to the Complaint to May 3, 2019 (*Reset Answer Deadlines: Sandoz AG answer due 5/3/2019; Sandoz International GmbH answer due 5/3/2019; Sandoz, Inc. answer due 5/3/2019). Signed by Judge Richard G. Andrews on 4/22/2019. (nms) (Entered: 04/23/2019)
4/19/2019 STIPULATION and Order to Extend Time to Answer, Move, or otherwise Respond to the Complaint to May 3, 2019 - filed by Sandoz AG, Sandoz International GmbH, Sandoz, Inc.. (Brauerman, Stephen) Modified on 4/23/2019 (nms). (Entered: 04/19/2019)
4/4/2019
  • Motion to Extend Time
SO ORDERED, re 11 STIPULATION TO EXTEND TIME for Defendants to Answer, Move, or otherwise Respond to the Complaint to April 19, 2019 (*Reset Answer Deadlines: Sandoz AG answer due 4/19/2019; Sandoz International GmbH answer due 4/19/2019; Sandoz, Inc. answer due 4/19/2019). Signed by Judge Richard G. Andrews on 4/4/2019. (nms) (Entered: 04/04/2019)
4/4/2019
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME for Defendants Sandoz, Inc., Sandoz International GmbH and Sandoz AG to Answer, Move, or otherwise Respond to the Complaint to April 19, 2019 - filed by Sandoz AG, Sandoz International GmbH, Sandoz, Inc.. (Brauerman, Stephen) (Entered: 04/04/2019)
3/27/2019
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 10 MOTION for Pro Hac Vice Appearance of Attorney Elaine Herrmann Blais, Natasha E. Daughtrey, Emily L. Rapalino, and Srikanth K. Reddy, filed by Sandoz AG, Sandoz, Inc., Sandoz International GmbH. Signed by Judge Richard G. Andrews on 3/27/2019. (nms) (Entered: 03/27/2019)
3/26/2019
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Elaine Herrmann Blais, Natasha E. Daughtrey, Emily L. Rapalino, and Srikanth K. Reddy - filed by Sandoz AG, Sandoz International GmbH, Sandoz, Inc.. (Attachments: # 1 Certification of Elaine Herrmann Blais, # 2 Certification of Natasha E. Daughtrey, # 3 Certification of Emily L. Rapalino, # 4 Certification of Srikanth K. Reddy)(Brauerman, Stephen) (Entered: 03/26/2019)
3/15/2019
  • Motion to Extend Time
SO ORDERED, re 9 STIPULATION and Order to Extend Time to Answer, Move or Otherwise Respond to the Complaint to April 5, 2019 (*Reset Answer Deadlines: Sandoz AG answer due 4/5/2019; Sandoz International GmbH answer due 4/5/2019; Sandoz, Inc. answer due 4/5/2019). Signed by Judge Richard G. Andrews on 3/15/2019. (nms) (Entered: 03/15/2019)
3/15/2019STIPULATION and Order to Extend Time for Defendant to Answer, Move or Otherwise Respond to the Complaint to April 5, 2019 - filed by Sandoz AG, Sandoz International GmbH, Sandoz, Inc.. (Brauerman, Stephen) Modified on 3/15/2019 (nms). (Entered: 03/15/2019)
3/8/2019Pro Hac Vice Attorneys Ryan Hagglund, Warren K. MacRae, and Mark E. Waddell for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00078-RGA et al.(ddp) (Entered: 03/08/2019)
2/12/2019
  • Motion to Extend Time
SO ORDERED, re 8 STIPULATION TO EXTEND TIME to Respond to the Complaint to March 15, 2019 (*Reset Answer Deadlines: Sandoz AG answer due 3/15/2019; Sandoz International GmbH answer due 3/15/2019; Sandoz, Inc. answer due 3/15/2019). Signed by Judge Richard G. Andrews on 2/12/2019. (nms) (Entered: 02/12/2019)
2/12/2019
  • Order
SO ORDERED, re (11 in 19-cv-78-RGA, 8 in 19-cv-154-RGA, 7 in 19-cv-202-RGA, 8 in 19-cv-130-RGA, 9 in 19-cv-103-RGA, 9 in 19-cv-110-RGA, 9 in 19-cv-123-RGA, 8 in 19-cv-205-RGA, 8 in 19-cv-219-RGA, 10 in 19-cv-178-RGA, 13 in 19-cv-131-RGA, 7 in 19-cv-223-RGA, 7 in 19-cv-142-RGA, 7 in 19-cv-136-RGA, 11 in 19-cv-104-RGA, 8 in 19-cv-190-RGA, 7 in 19-cv-141-RGA, 8 in 19-cv-177-RGA, 13 in 19-cv-132-RGA, 9 in 1:19-cv-00120-RGA, 8 in 19-cv-111-RGA, 8 in 19-cv-195-RGA, 9 in 19-cv-105-RGA, 9 in 1:19-cv-00109-RGA, 7 in 19-cv-203-RGA, 10 in 19-cv-164-RGA) MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 2/12/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) (Entered: 02/12/2019)
2/11/2019
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME for Defendants to Respond to the Complaint to March 15, 2019 - filed by Sandoz AG, Sandoz International GmbH, Sandoz, Inc.. (Brauerman, Stephen) (Entered: 02/11/2019)
2/11/2019
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) (Entered: 02/11/2019)
2/6/2019Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00177-RGA, 1:19-cv-00178-RGA, 1:19-cv-00190-RGA, 1:19-cv-00195-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA, 1:19-cv-00205-RGA, 1:19-cv-00219-RGA, 1:19-cv-00223-RGA (rjb) (Entered: 02/06/2019)
2/4/2019AFFIDAVIT of Service for Summons, Complaint and related papers served on Sandoz, Inc., c/o Emily Rapalino, Goodwin Procter LLP on February 1, 2019, filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) (Entered: 02/04/2019)
1/31/2019Summons Issued with Magistrate Consent Notice attached as to Sandoz AG on 1/31/2019; Sandoz International GmbH on 1/31/2019; Sandoz, Inc. on 1/31/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) (Entered: 01/31/2019)
1/31/2019 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Roche Holding Ltd., Other Affiliate Novartis Ltd., Other Affiliate Roche Holdings, Inc. for Genentech, Inc.; Other Affiliate Genentech, Inc. for InterMune, Inc. filed by Genentech, Inc., InterMune, Inc. (lak) (Entered: 01/31/2019)
1/31/2019Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See attachment. (lak) (Entered: 01/31/2019)
1/31/2019 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/20/2018. Date of Expiration of Patent: See attachment.Thirty Month Stay Deadline: 4/15/2022. (lak) (Entered: 01/31/2019)
1/31/2019Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) (Entered: 01/31/2019)
1/31/2019
  • Complaint
COMPLAINT FOR PATENT INFRINGEMENT - filed against Sandoz AG, Sandoz International GmbH, Sandoz, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2558750.) - filed by InterMune, Inc., Genentech, Inc.. (Attachments: # 1 Exhibit 1-19, # 2 Civil Cover Sheet)(lak) (Entered: 01/31/2019)